Purpose To provide evidence-based recommendations to update the American Society of
Clinical Oncology guideline on systemic therapy for stage IV non–small-cell lung cancer …

Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on
systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC). Methods …

The purpose of this article is to provide updated recommendations for the treatment of
patients with stage IV non–small-cell lung cancer. A literature search identified relevant …

Background Stage IV non-small cell lung cancer (NSCLC) is a treatable, but not curable,
clinical entity in patients given the diagnosis at a time when their performance status (PS) …

Purpose An American Society of Clinical Oncology (ASCO) focused update updates a single
recommendation (or subset of recommendations) in advance of a regularly scheduled …

The prognosis for patients with relapsed/progressive non-small cell lung cancer (NSCLC)
remains poor. For first-line therapy, a number of platinum-based regimens are standard; …

PURPOSE The aim of this work is to provide evidence-based recommendations updating
the 2017 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung …

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy
for Stage IV Non–Small-Cell Lung Cancer | JCO Oncology Practice Skip to main content …

Background Stage IV non-small cell lung cancer (NSCLC) remains a treatable but incurable
disease. Methods A MEDLINE search was performed to identify pertinent peer-reviewed …

PURPOSE To provide evidence-based recommendations updating the 2017 ASCO
guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC) …